lomerizine has been researched along with Cranial Nerve II Diseases in 1 studies
lomerizine: used to treat migraines
| Excerpt | Relevance | Reference |
|---|---|---|
| "Pre-treatment with tacrolimus markedly protected RGC-5 cells from NMDA-induced neurotoxicity, and then both spontaneous RGC death and degenerative changes to the optic nerve in p50-deficient mice were significantly reduced by the chronic administration of tacrolimus." | 1.37 | Development of spontaneous neuropathy in NF-κBp50-deficient mice by calcineurin-signal involving impaired NF-κB activation. ( Hayashi, T; Murata, T; Nakamura-Yanagidaira, T; Sano, K; Takahashi, Y, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nakamura-Yanagidaira, T | 1 |
| Takahashi, Y | 1 |
| Sano, K | 1 |
| Murata, T | 1 |
| Hayashi, T | 1 |
1 other study available for lomerizine and Cranial Nerve II Diseases
| Article | Year |
|---|---|
Development of spontaneous neuropathy in NF-κBp50-deficient mice by calcineurin-signal involving impaired NF-κB activation.
Topics: Animals; Apoptosis; bcl-2-Associated X Protein; Blotting, Western; Calcineurin; Genes, Reporter; Hum | 2011 |